Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer.

Kumar J, Murugaiah V, Sotiriadis G, Kaur A, Jeyaneethi J, Sturniolo I, Alhamlan FS, Chatterjee J, Hall M, Kishore U, Karteris E.

Front Oncol. 2019 Jul 9;9:542. doi: 10.3389/fonc.2019.00542. eCollection 2019.

2.

Detection of Abundant Non-Haematopoietic Circulating Cancer-Related Cells in Patients with Advanced Epithelial Ovarian Cancer.

Kumar J, Chudasama D, Roberts C, Kubista M, Sjöback R, Chatterjee J, Anikin V, Karteris E, Hall M.

Cells. 2019 Jul 17;8(7). pii: E732. doi: 10.3390/cells8070732.

3.

Engineered human mesenchymal stem cells for neuroblastoma therapeutics.

Nieddu V, Piredda R, Bexell D, Barton J, Anderson J, Sebire N, Kolluri K, Janes SM, Karteris E, Sala A.

Oncol Rep. 2019 Jul;42(1):35-42. doi: 10.3892/or.2019.7152. Epub 2019 May 8.

4.

Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications.

Chudasama D, Katopodis P, Stone N, Haskell J, Sheridan H, Gardner B, Urnovitz H, Schuetz E, Beck J, Hall M, Barr J, Sisu C, Rice A, Polychronis A, Anikin V, Karteris E.

Cancers (Basel). 2019 Mar 7;11(3). pii: E331. doi: 10.3390/cancers11030331.

5.

Involvement of the glutamine RF‑amide peptide and its cognate receptor GPR103 in prostate cancer.

Kawan MA, Kyrou I, Ramanjaneya M, Williams K, Jeyaneethi J, Randeva HS, Karteris E.

Oncol Rep. 2019 Feb;41(2):1140-1150. doi: 10.3892/or.2018.6893. Epub 2018 Nov 27.

6.

Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection.

Patel VH, Karteris E, Chen J, Kyrou I, Mattu HS, Dimitriadis GK, Rodrigo G, Antoniades C, Antonopoulos A, Tan BK, Hillhouse EW, Ng A, Randeva HS.

Clin Sci (Lond). 2018 Dec 13;132(24):2547-2564. doi: 10.1042/CS20180150. Print 2018 Dec 21.

7.

Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry.

Rogers-Broadway KR, Kumar J, Sisu C, Wander G, Mazey E, Jeyaneethi J, Pados G, Tsolakidis D, Klonos E, Grunt T, Hall M, Chatterjee J, Karteris E.

Int J Mol Med. 2019 Jan;43(1):47-56. doi: 10.3892/ijmm.2018.3967. Epub 2018 Oct 31.

8.

Prognostic value of the DNA integrity index in patients with malignant lung tumors.

Chudasama DY, Aladag Z, Felicien MI, Hall M, Beeson J, Asadi N, Gidron Y, Karteris E, Anikin VB.

Oncotarget. 2018 Apr 20;9(30):21281-21288. doi: 10.18632/oncotarget.25086. eCollection 2018 Apr 20.

9.

Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.

Chudasama D, Bo V, Hall M, Anikin V, Jeyaneethi J, Gregory J, Pados G, Tucker A, Harvey A, Pink R, Karteris E.

Carcinogenesis. 2018 Mar 8;39(3):407-417. doi: 10.1093/carcin/bgx122.

10.

Perioperative detection of circulating tumour cells in patients with lung cancer.

Chudasama D, Burnside N, Beeson J, Karteris E, Rice A, Anikin V.

Oncol Lett. 2017 Aug;14(2):1281-1286. doi: 10.3892/ol.2017.6366. Epub 2017 Jun 9.

11.

Inertia based microfluidic capture and characterisation of circulating tumour cells for the diagnosis of lung cancer.

Chudasama DY, Freydina DV, Freidin MB, Leung M, Montero Fernandez A, Rice A, Nicholson AG, Karteris E, Anikin V, Lim E.

Ann Transl Med. 2016 Dec;4(24):480. doi: 10.21037/atm.2016.12.28.

12.

Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells.

Wagner R, Stübiger G, Veigel D, Wuczkowski M, Lanzerstorfer P, Weghuber J, Karteris E, Nowikovsky K, Wilfinger-Lutz N, Singer CF, Colomer R, Benhamú B, López-Rodríguez ML, Valent P, Grunt TW.

Oncotarget. 2017 Feb 14;8(7):11600-11613. doi: 10.18632/oncotarget.14591.

13.

Human C1q Induces Apoptosis in an Ovarian Cancer Cell Line via Tumor Necrosis Factor Pathway.

Kaur A, Sultan SH, Murugaiah V, Pathan AA, Alhamlan FS, Karteris E, Kishore U.

Front Immunol. 2016 Dec 21;7:599. doi: 10.3389/fimmu.2016.00599. eCollection 2016.

14.

Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro.

Rogers-Broadway KR, Chudasama D, Pados G, Tsolakidis D, Goumenou A, Hall M, Karteris E.

Int J Oncol. 2016 Jul;49(1):133-43. doi: 10.3892/ijo.2016.3531. Epub 2016 May 18.

15.

The pro-social neurohormone oxytocin reverses the actions of the stress hormone cortisol in human ovarian carcinoma cells in vitro.

Mankarious A, Dave F, Pados G, Tsolakidis D, Gidron Y, Pang Y, Thomas P, Hall M, Karteris E.

Int J Oncol. 2016 May;48(5):1805-14. doi: 10.3892/ijo.2016.3410. Epub 2016 Mar 1.

16.

Surfactant Proteins SP-A and SP-D Modulate Uterine Contractile Events in ULTR Myometrial Cell Line.

Sotiriadis G, Dodagatta-Marri E, Kouser L, Alhamlan FS, Kishore U, Karteris E.

PLoS One. 2015 Dec 7;10(12):e0143379. doi: 10.1371/journal.pone.0143379. eCollection 2015.

17.

Amplification efficiency and thermal stability of qPCR instrumentation: Current landscape and future perspectives.

Rogers-Broadway KR, Karteris E.

Exp Ther Med. 2015 Oct;10(4):1261-1264. Epub 2015 Aug 25.

18.

Orexin receptors exert a neuroprotective effect in Alzheimer's disease (AD) via heterodimerization with GPR103.

Davies J, Chen J, Pink R, Carter D, Saunders N, Sotiriadis G, Bai B, Pan Y, Howlett D, Payne A, Randeva H, Karteris E.

Sci Rep. 2015 Jul 30;5:12584. doi: 10.1038/srep12584.

19.

Heterodimerization of apelin receptor and neurotensin receptor 1 induces phosphorylation of ERK(1/2) and cell proliferation via Gαq-mediated mechanism.

Bai B, Cai X, Jiang Y, Karteris E, Chen J.

J Cell Mol Med. 2014 Oct;18(10):2071-81. doi: 10.1111/jcmm.12404. Epub 2014 Aug 28.

20.

Elucidating the role of DEPTOR in Alzheimer's disease.

Davies J, Zachariades E, Rogers-Broadway KR, Karteris E.

Int J Mol Med. 2014 Nov;34(5):1195-200. doi: 10.3892/ijmm.2014.1895. Epub 2014 Aug 12.

21.

Differential expression of placental glucocorticoid receptors and growth arrest-specific transcript 5 in term and preterm pregnancies: evidence for involvement of maternal stress.

Mparmpakas D, Zachariades E, Sotiriadis G, Goumenou A, Harvey AJ, Gidron Y, Karteris E.

Obstet Gynecol Int. 2014;2014:239278. doi: 10.1155/2014/239278. Epub 2014 May 11.

22.

QRFP induces aldosterone production via PKC and T-type calcium channel-mediated pathways in human adrenocortical cells: evidence for a novel role of GPR103.

Ramanjaneya M, Karteris E, Chen J, Rucinski M, Ziolkowska A, Ahmed N, Kagerer S, Jöhren O, Lehnert H, Malendowicz LK, Randeva HS.

Am J Physiol Endocrinol Metab. 2013 Nov 1;305(9):E1049-58. doi: 10.1152/ajpendo.00191.2013. Epub 2013 Aug 20.

23.

The human myometrium differentially expresses mTOR signalling components before and during pregnancy: evidence for regulation by progesterone.

Foster HA, Davies J, Pink RC, Turkcigdem S, Goumenou A, Carter DR, Saunders NJ, Thomas P, Karteris E.

J Steroid Biochem Mol Biol. 2014 Jan;139:166-72. doi: 10.1016/j.jsbmb.2013.02.017. Epub 2013 Mar 26.

24.

Immune system function, stress, exercise and nutrition profile can affect pregnancy outcome: Lessons from a Mediterranean cohort.

Mparmpakas D, Goumenou A, Zachariades E, Pados G, Gidron Y, Karteris E.

Exp Ther Med. 2013 Feb;5(2):411-418. Epub 2012 Dec 4.

25.

Changes in placental progesterone receptors in term and preterm labour.

Zachariades E, Mparmpakas D, Pang Y, Rand-Weaver M, Thomas P, Karteris E.

Placenta. 2012 May;33(5):367-72. doi: 10.1016/j.placenta.2012.01.002. Epub 2012 Feb 16.

PMID:
22341631
26.

Crucial cross-talk of interleukin-1β and progesterone in human choriocarcinoma.

Zachariades E, Mparmpakas D, Thomas P, Rand-Weaver M, Karteris E.

Int J Oncol. 2012 May;40(5):1358-64. doi: 10.3892/ijo.2012.1349. Epub 2012 Jan 27.

PMID:
22294087
27.

Placental DEPTOR as a stress sensor during pregnancy.

Mparmpakas D, Zachariades E, Goumenou A, Gidron Y, Karteris E.

Clin Sci (Lond). 2012 Apr;122(7):349-59. doi: 10.1042/CS20110378.

28.

Expression of membrane and nuclear progesterone receptors in two human placental choriocarcinoma cell lines (JEG-3 and BeWo): Effects of syncytialization.

Zachariades E, Foster H, Goumenou A, Thomas P, Rand-Weaver M, Karteris E.

Int J Mol Med. 2011 Jun;27(6):767-74. doi: 10.3892/ijmm.2011.657. Epub 2011 Mar 23.

PMID:
21455559
29.

Differential expression of mTOR signalling components in drug resistance in ovarian cancer.

Foster H, Coley HM, Goumenou A, Pados G, Harvey A, Karteris E.

Anticancer Res. 2010 Sep;30(9):3529-34.

PMID:
20944133
30.

Identification of a novel corticotropin-releasing hormone type 1beta-like receptor variant lacking Exon 13 in human pregnant myometrium regulated by estradiol-17beta and progesterone.

Karteris E, Markovic D, Chen J, Hillhouse EW, Grammatopoulos DK.

Endocrinology. 2010 Oct;151(10):4959-68. doi: 10.1210/en.2010-0622. Epub 2010 Aug 11.

PMID:
20702571
31.

G-protein coupled estrogen receptor 1 expression in rat and human heart: Protective role during ischaemic stress.

Patel VH, Chen J, Ramanjaneya M, Karteris E, Zachariades E, Thomas P, Been M, Randeva HS.

Int J Mol Med. 2010 Aug;26(2):193-9.

PMID:
20596598
32.

Internalisation of membrane progesterone receptor-α after treatment with progesterone: Potential involvement of a clathrin-dependent pathway.

Foster H, Reynolds A, Stenbeck G, Dong J, Thomas P, Karteris E.

Mol Med Rep. 2010 Jan-Feb;3(1):27-35. doi: 10.3892/mmr_00000214.

PMID:
21472196
33.

Congenital imperforate hymen with hydrocolpos and hydronephrosis associated with severe hydramnios and increase of maternal ovarian steroidogenic enzymes.

Karteris E, Foster H, Karamouti M, Goumenou A.

J Pediatr Adolesc Gynecol. 2010 Jun;23(3):136-41. doi: 10.1016/j.jpag.2009.10.002. Epub 2009 Dec 5.

PMID:
19963411
34.

Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines.

Mparmpakas D, Zachariades E, Foster H, Kara A, Harvey A, Goumenou A, Karteris E.

Int J Mol Med. 2010 Jan;25(1):65-9.

PMID:
19956903
35.

Differential expression of mouse orexin receptor type-2 (OX2R) variants in the mouse brain.

Chen J, Karteris E, Collins D, Randeva HS.

Brain Res. 2006 Aug 4;1103(1):20-4. Epub 2006 Jun 27.

PMID:
16806113
36.

Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma.

Mottershead M, Karteris E, Barclay JY, Suortamo S, Newbold M, Randeva H, Nwokolo CU.

J Clin Pathol. 2007 Apr;60(4):405-9. Epub 2006 Jun 2.

37.

Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines.

Chen J, Tan B, Karteris E, Zervou S, Digby J, Hillhouse EW, Vatish M, Randeva HS.

Diabetologia. 2006 Jun;49(6):1292-302. Epub 2006 Mar 29.

PMID:
16570162
38.

Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term.

Karteris E, Zervou S, Pang Y, Dong J, Hillhouse EW, Randeva HS, Thomas P.

Mol Endocrinol. 2006 Jul;20(7):1519-34. Epub 2006 Feb 16.

PMID:
16484338
39.
40.

Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex.

Karteris E, Machado RJ, Chen J, Zervou S, Hillhouse EW, Randeva HS.

Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1089-100. Epub 2005 Jan 25.

41.

The role of hCG in reproductive medicine.

Keay SD, Vatish M, Karteris E, Hillhouse EW, Randeva HS.

BJOG. 2004 Nov;111(11):1218-28. Review. No abstract available.

42.

Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin.

Parham KL, Zervou S, Karteris E, Catalano RD, Old RW, Hillhouse EW.

Endocrinology. 2004 Aug;145(8):3971-83. Epub 2004 May 13.

PMID:
15142984
43.

Expression of human prepro-orexin and signaling characteristics of orexin receptors in the male reproductive system.

Karteris E, Chen J, Randeva HS.

J Clin Endocrinol Metab. 2004 Apr;89(4):1957-62.

PMID:
15070969
44.

Expression and signalling characteristics of the corticotrophin-releasing hormone receptors during the implantation phase in the human endometrium.

Karteris E, Papadopoulou N, Grammatopoulos DK, Hillhouse EW.

J Mol Endocrinol. 2004 Feb;32(1):21-32.

PMID:
14765990
45.

The Glu298-->Asp polymorphism of the endothelial nitric oxide synthase gene is associated with endometriosis.

Zervou S, Karteris E, Goumenou AG, Vatish M, Koumantakis EE, Hillhouse EW.

Fertil Steril. 2003 Dec;80(6):1524-5. No abstract available.

PMID:
14667898
47.

Orexin receptors and G-protein coupling: evidence for another "promiscuous" seven transmembrane domain receptor.

Karteris E, Randeva HS.

J Pharmacol Sci. 2003 Sep;93(1):126-8. No abstract available.

48.

Circadian rhythmicity of salivary leptin in healthy subjects.

Randeva HS, Karteris E, Lewandowski KC, Sailesh S, O'Hare P, Hillhouse EW.

Mol Genet Metab. 2003 Mar;78(3):229-35.

PMID:
12649069
49.

Reduced expression of corticotropin-releasing hormone receptor type-1 alpha in human preeclamptic and growth-restricted placentas.

Karteris E, Goumenou A, Koumantakis E, Hillhouse EW, Grammatopoulos DK.

J Clin Endocrinol Metab. 2003 Jan;88(1):363-70.

PMID:
12519878
50.

Steroids mediate the expression of cytoplasmic and membrane-linked components in human myometrial cells.

Zervou S, Karteris E, Hillhouse EW, Old RW.

Mol Hum Reprod. 2002 Jul;8(7):597-605.

PMID:
12087073

Supplemental Content

Loading ...
Support Center